20152 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate; Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals; Wall or coating material; Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
Pharmaceutical Compositions Comprising Amorphous Esomeprazole, Dosage Forms And Process Thereof
#902Abuse resistant drugs, method of use and method of making
#903Abuse resistant forms of extended release morphine, method of use and method of making
#904MICROPARTICLES COMPRISING POLYMERS WITH THIOESTER BONDS
#905Abuse resistant forms of extended release morphine with oxycodone, method of use and method of making
#906Abuse resistant forms of extended release hydrocodone, method of use and method of making
#907Abuse resistant forms of extended release oxymorphone, method of use and method of making
#908Abuse resistant forms of extended release oxycodone, method of use, and method of making
#909Abuse resistant forms of extended release hydromorphone, method of use and method of making
#910Amphiphilic polymer functionalized by methionine
#911Sustained-release composition and method for producing the same
#912Ondansetron Orally Disintegrating Tablet Compositions for Prevention of Nausea and Vomiting
#913Method of producing polymeric particles with selected size, shape, morphology and composition
#914PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF SOMATOSTATIN OR AN ANALOGUE THEREOF
#915MODIFIED RELEASE NIACIN FORMULATIONS
#916ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#917Intravenous infusion of curcumin and a calcium channel blocker
#918Methods of using lipolytic formulations for regional adipose tissue treatment
#919MICROPARTICLE COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION
#920Tamper-resistant oral opioid agonist formulations
#921CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS
#922Abuse resistant drugs, method of use and method of making
#923ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#924ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#925Capsule of thermogenic cells for treating a metabolic disease
#926Methods and apparatus for pulsatile release of medicaments from a punctal plug
#927Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
#928Nanoparticles for delivery of active agents
#929Nanoparticles for delivery of active agents
#930Pancreatine pellets and method of producing same
#931Sustained release systems and preparation method thereof
#932Dendrimers for sustained release of compounds
#933Methods and compositions for treatment of ion imbalances
#934ARTICLES AND METHODS FOR REPAIRING DAMAGED NERVOUS TISSUE
#935Hollow Multi-Layered Microspheres for Delivery of Hydrophilic Active Compounds
#936AN IMPLANTABLE DRUG DEPOT HAVING A REVERSIBLE PHASE TRANSITION MATERIAL FOR TREATMENT OF PAIN AND/OR INFLAMMATION
#937POROUS POLYMER PARTICLES IMMOBILIZED WITH CHARGED MOLECULES AND METHOD FOR PREPARING THE SAME
#938Dry to wet injector
#939Abuse resistant oral opioid formulations
#940STABILIZATION OF MACROMOLECULAR MEMBRANES
#941Drug delivery compositions including nanoshells for triggered drug release
#942Microparticles for the treatment of disease
#943PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PARKINSON'S DISEASE AND RELATED DISORDERS
#944Dispersion of poloxamer-protein particles, methods of manufacturing and uses thereof
#945Controlled-release floating pharmaceutical compositions
#946Aqueous Film Coating Composition / 841
#947Orally disintegrating tablet compositions of lamotrigine
#948Method and apparatus for in situ drug delivery during distraction osteogenesis
#949ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#950Antibiotic formulation and method of treatment
#951MICROPARTICLE COMPRISING CROSS-LINKED POLYMER
#952NANOCELL DRUG DELIVERY SYSTEM
#953MICROCAPSULES COMPRISING LIVER CELLS AND ERYTHROPOIETIN, METHODS FOR PREPARING SAID MICROCAPSULES AND METHODS FOR TREATING A PATIENT COMPRISING APPLYING SAID MICROCAPSULES TO THE PATIENT
#954OCULAR THERAPEUTIC AGENT DELIVERY DEVICES AND METHDOS FOR MAKING AND USING SUCH DEVICES
#955Microencapsulated compositions and methods for tissue mineralization
#956USE OF INSULIN FOR THE TREATMENT OF CARTILAGINOUS DISORDERS
#957System for targeted delivery of therapeutic agents
#958INDUCTION OF IMMUNOLOGICAL TOLERANCE
#959STABILIZED ANTIOXIDANT PARTICLES, COMPOSITION COMPRISING THE SAME AND METHOD FOR PREPARING THE SAME
#960Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
#961Anti-angiogenic nanoparticle compositions
#962Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein
#963Bi-functional co-polymer use for opthalmic and other topical and local applications
#964PROCESS FOR THE PREPARATION OF CONTROLLED-RELEASE SOLID FORMULATIONS CONTAINING OXCARBAZEPINE, AND FORMULATIONS OBTAINABLE BY SAID PROCESS
#965METHOD FOR PRODUCING A PARTICLE COMPRISING A GAS CORE AND A SHELL AND PARTICLES THUS OBTAINED
#966SWELLABLE HYALURONIC ACID PARTICLES
#967Microparticles comprising PCL and uses thereof
#968Particle size-structured parenteral dispersions
#969TDF-related compounds and analogs thereof, analogs and bioactive fragments
#970Microspheres having core/shell structure
#971CONTINOUS DOUBLE EMULSION PROCESS FOR MAKING MICROPARTICLES
#972Extended-Release Composition Comprising a Somatostatin Derivative in Microparticles
#973MICROPARTICLE FORMULATIONS FOR SUSTAINED-RELEASE OF BIOACTIVE COMPOUNDS
#974Controlled release implantable dispensing device and method
#975Oxycontin controlled release formulations and methods of using same
#976Cross-linked alginate-polyalkylene glycol polymer coatings for encapsulation and methods of making the same
#977Sustained release formulations of psychoactive drugs
#978Magnetic microsphere and method of forming a microsphere
#979Method for treating infectious organisms normally considered to be resistant to an antimicrobial drug
#980THERAPEUTIC AGENT FOR SPINAL CORD INJURIES
#981Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein
#982Cell and enzyme compositions for modulating ale acids, cholesterol and triglycerides
#983Microencapsulation process with solvent and salt
#984Solvent extraction microencapsulation with tunable extraction rates
#985Ceramic implants affording controlled release of active materials
#986ORGANIC COMPOUNDS
#987P-Glycoprotein inhibitor comprising octilonium bromide as an effective ingredient
#988Controlled-release immunogenic formulations to modulate immune response
#989Injectable delivery of microparticles and compositions therefore
#990Method for producing microspheres loaded with drugs and microspheres loaded with drugs produced thereby
#991Solid dosage form of coated bisphosphonate particles
#992Method for the Encapsulation and Controlled Release of Poorly Water-Soluble (Hyprophobic) Liquid and Solid Active Ingredients
#993Microparticles For The Treatment Of Disease
#994Kinase inhibitors
#995Microencapsulation and sustained release of biologically active polypeptides
#996MULTIFUNCTIONAL POLYMERIC TISSUE COATINGS
#997Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation
#998Antioxidant polymer nanocarriers for use in preventing oxidative injury
#999Carbon-substituted diketopiperazine delivery systems
#1000Method and process for the production of multi-coated recognitive and releasing systems
#1001Porous Drug Delivery Devices and Related Methods
#1002Drug Delivery System Comprising Microparticles and Gelation System
#1003Bupivacaine formulation in a polyorthoester carrier
#1004Applications of microencapsulated essential oils
#1005Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
#1006Sustained release composition and manufacturing method thereof
#1007Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications
#1008Zolpidem pharmaceutical compositions
#1009Ion binding compositions
#1010Sol-gel phase-reversible hydrogel templates and uses thereof
#1011CHRONOTHERAPEUTIC DILTIAZEM FORMULATIONS AND THE ADMINISTRATION THEREOF
#1012LOADABLE POLYMERIC PARTICLES FOR BONE AUGMENTATION AND METHODS OF PREPARING AND USING THE SAME
#1013SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS
#1014Loadable Polymeric Particles for Cosmetic and Reconstructive Tissue Augmentation Applications and Methods of Preparing and Using the Same
#1015Loadable Polymeric Microparticles for Therapeutic Use in Alopecia and Methods of Preparing and Using the Same
#1016Implantable device having a slow dissolving polymer
#1017Gonadotropin releasing hormone antagonists
#1018PROCESS OF MAKING MICROSPHERES
#1019Long term drug delivery devices with polyurethane based polymers and their manufacture
#1020Orally disintegrating tablet compositions of lamotrigine
#1021ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#1022Controlled release interferon drug products and treatment of HCV infections using same
#1023Compositions and methods for delivery of poorly soluble drugs
#1024ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#1025ELECTROSPRAYING METHOD FOR FABRICATION OF PARTICLES AND COATINGS AND TREATMENT METHODS THEREOF
#1026Coated Hyaluronic Acid Particles
#1027Nucleic acid microparticles for pulmonary delivery
#1028IMPLANTATION OF ENCAPSULATED BIOLOGICAL MATERIALS FOR TREATING DISEASES
#1029INDUCTION OF IMMUNOLOGICAL TOLERANCE
#1030Tamper-resistant oral opioid agonist formulations
#1031Tamper-resistant oral opioid agonist formulations
#1032Tamper-resistant oral opioid agonist formulations
#1033AMORPHOUS DRUG BEADS
#1034Tamper-resistant oral opioid agonist formulations
#1035Oral Medicament For The Modified Release Of At Least One Active Principle, In Multimicrocapsule Form
#1036Dosage forms for movement disorder treatment
#1037Endogeneous repair factor production promoters
#1038GELS FOR ENCAPSULATION OF BIOLOGICAL MATERIALS
#1039Encapsulation and Controlled Release of Biologically Active Ingredients with Enzymatically Degradable Microparticulate, Hyperbranched Polymers
#1040Solid, Oral, Microparticulate Dosage Form Which Has Been Designed To Prevent Misuse
#1041Microencapsules Containing Surface-Modified Microparticles And Methods Of Forming And Using The Same
#1042Ion binding polymers and uses thereof
#1043Ion binding polymers and uses thereof
#1044Coacervation Process
#1045Method for delivering a peptide to a subject at a modulated rate via microcapsules of lactic-co-glycolic copolymer containing said peptide
#1046Ion binding polymers and uses thereof
#1047Cross-linked polymer particles
#1048POLYMER PARTICLES
#1049CHEMICALLY CROSS-LINKED ELASTOMERIC MICROCAPSULES
#1050MICROPARTICLES
#1051Drugs and gene carrier particles that rapidly move through mucous barriers
#1052ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#1053Intraocular drug delivery systems
#1054Therapeutic Agent for Pruritus Comprising P38 Map Kinase Inhibitor as the Active Ingredient
#1055POLYMER COATED DRUG-ION EXCHANGE RESINS AND METHODS
#1056Bis(thiohydrazide amides) formulation
#1057Sustained-Release Composition, Process for Producing the Same and Use of the Same
#1058Microparticles and Nanoparticles for the Transmucosal Delivery of Therapeutic and Diagnostic Agents
#1059Encapsulated Nanoparticles for Drug Delivery
#1060Intrathecal Injection of Microbubbles Containing a Thrombolytic Agent
#1061INTRATHECAL INJECTION OF MICROBUBBLES
#1062POLYMER-ENCAPSULATED MICROSPHERES
#1063Prolonged-release multimicroparticulate oral pharmaceutical form
#1064Apparatus and method for preparing microparticles using in-line solvent extraction
#1065Apparatus and method for preparing microparticles using in-line solvent extraction
#1066DEVICE FOR IMPROVED PEPTIDE DELIVERY
#1067ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#1068Methods and devices for forming treatment agent carriers
#1069CARBON-SUBSTITUTED DIKETOPIPERAZINE DELIVERY SYSTEMS
#1070Nanoshells on polymers
#1071ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#1072Delivery of ophthalmologic agents to the exterior or interior of the eye
#1073Protein Sustained-Release Microparticle Preparation for Injection and Process for Producing the Same
#1074Lactic acid polymer and process for producing the same
#1075ANTIBIOTIC FORMULATION AND METHOD OF TREATMENT
#1076Method for treating warm-blooded vertebrates with a salt of a halide-free glucosamine base and a therapeutic drug
#1077Use of azurocidin inhibitors in prevention and treatment of ocular vascular leakage
#1078Biocompatible microcapsules
#1079Nanoparticles for delivery of active agents
#1080Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
#1081Polypeptide films and methods
#1082Pharmaceutical compositions with enhanced stability
#1083OCULAR THERAPEUTIC AGENT DELIVERY DEVICES AND METHODS FOR MAKING AND USING SUCH DEVICES
#1084Microencapsulation of pancreatic islets within a thin coat of glucagon-like peptide-1 functionalized poly(ethylene glycol)
#1085Pharmaceutical composition and process
#1086Latex or pseudolatex compositions, coatings and coating processes
#1087Biocompatible polymeric delivery systems for sustained release of quinazolinones
#1088Coating method
#1089Dosage forms for movement disorder treatment
#1090Delayed release pancreatin compositions
#1091CELLULAR ENCAPSULATION FOR SELF-ASSEMBLY OF ENGINEERED TISSUE
#1092Parenterally administrable microparticles
#1093Subcutaneous implants having limited initial release of the active principle and subsequent linearly varying extended release thereof
#1094Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides
#1095Gels for encapsulation of biological materials
#1096Compositions for administering RNAIII-inhibiting peptides
#1097Controlled release compositions
#1098Materials and methods for preparing protein-polymer conjugates
#1099Apparatus for preparing biodegradable microparticle formulations containing pharmaceutically active agents
#1100Composition of polymer microcapsules of biocide for coating material
#1101Polysaccharide-functionalized nanoparticle, drug delivery system for controlled release comprising the same and preparation method thereof
#1102Nanocell drug delivery system
#1103Use of Insulin for the Treatment of Cartilaginous Disorders
#1104Microencapsulation and sustained release of biologically active polypeptides
#1105Sustained release enhanced lipolytic formulation for regional adipose tissue treatment
#1106Microencapsulation of particles in a polymer solution by selective withdrawal through a high viscosity low density fluid and subsequent crosslinking
#1107Anti-angiogenic compositions and methods of use
#1108Anti-angiogenic compositions and methods of use
#1109Dosage forms for movement disorder treatment
#1110Drug delivery device
#1111Novel biodegradable aliphatic polyesters and pharmaceutical compositions and applications thereof
#1112Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
#1113Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
#1114Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
#1115Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
#1116Formulation and Method for Preventing Infection
#1117Modified release, multiple unit drug delivery systems
#1118Microcapsules containing biocide and preparation thereof by solvent evaporation technique
#1119Method for producing preparation containing bioactive substance
#1120Anti-angiogenic compositions and methods of use
#1121Cellulosic films incorporating a pharmaceutically acceptable plasticizer with enhanced wettability
#1122Method for the treatment of prostate cancer
#1123Controlled release compositions of gamma-hydroxybutyrate
#1124In situ controlled release drug delivery system
#1125Polymer particle delivery compositions and methods of use
#1126Treating morning migraines with propranolol
#1127Coating composition for taste masking coating and methods for their application and use
#1128P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient
#1129Lactic acid polymer and process for producing the same
#1130Anti-angiogenic compositions and methods of use
#1131Antioxidant polymer nanocarriers for use in preventing oxidative injury
#1132Multifunctional polymeric tissue coatings
#1133Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous-aqueous emulsion
#1134Anti-angiogenic compositions and methods of use
#1135Compositions and methods for treating or preventing diseases of body passageways
#1136Anti-microbial composition using in-situ generation of an oxidizing agent
#1137Loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
#1138Enteric coated aspirin granules comingled with binder
#1139Sustained-release preparations
#1140Endogenous repair factor production accelerator
#1141Polymeric microparticulates for sustained release of drug and their preparation methods
#1142Nanoparticles containing polymeric nucleic acid homologs
#1143Method of microencapsulation
#1144Microcapsules for stabilization of cosmetic, pharmaceutical or food products
#1145Controlled regional oral delivery
#1146Tamper-resistant oral opioid agonist formulations
#1147Antidiabetic preparation for oral administration
#1148Ion binding compositions
#1149Methods and compositions for treatment of ion imbalances
#1150Method of encapsulating hydrophobic organic molecules in polyurea capsules
#1151Lactone bearing absorbable polymers
#1152Method and apparatus for preparing microparticles using in-line solvent extraction
#1153Resorbable matrices with coatings for delivery of bioactive compounds
#1154Co-encapsulated WT1 polypeptide and immunostimulant microsphere formulations and methods thereof
#1155Low molecular weight polymers
#1156Preparation of further diagnostic agents
#1157Methods for fabrication, uses and compositions of small spherical particles of insulin prepared by controlled phase separation
#1158Ion binding compositions
#1159Ion binding compositions
#1160Ion binding polymers and uses thereof
#1161Microparticle formulations for sustained-release of bioactive compounds
#1162Anti-angiogenic compositions and methods of use
#1163Compositions and methods for treating or preventing diseases of body passageways
#1164Polymer coating/encapsulation of nanoparticles using a supercritical antisolvent process
#1165Nanoparticulate therapeutic biologically active agents
#1166Tamper-resistant oral opioid agonist formulations
#1167Methods for fabrication, uses and compositions of small spherical particles of AAT prepared by controlled phase separation
#1168Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation
#1169Methods for fabrication, uses and compositions of small spherical particles of hGH prepared by controlled phase separation
#1170Carbon-substituted diketopiperazine delivery systems
#1171Compositions and methods for treating or preventing diseases of body passageways
#1172Compositions and methods for treating or preventing diseases of body passageways
#1173Biodegradable, antibiotic, controlled release tape
#1174Method of producing micro-capsules for the sustained release of drugs
#1175Anti-angiogenic compositions and methods of use
#1176pH-triggered microparticles
#1177Powder formulation comprising conjugated octadecapolyenic acids
#1178Compositions and methods for treating or preventing diseases of body passageways
#1179Drug-enhanced adhesion prevention
#1180Drug-enhanced adhesion prevention
#1181Compositions and methods for treating or preventing diseases of body passageways
#1182Compositions and methods for treating or preventing diseases of body passageways
#1183Tamper-resistant oral opioid agonist formulations
#1184Model for testing immunogenicity of peptides
#1185Bioadhesive drug delivery system with enhanced gastric retention
#1186Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
#1187Bioerodible sustained release drug delivery systems
#1188Edible capsules
#1189GHB formulation and method for its manufacture
#1190GHB formulation and method for its manufacture
#1191GHB formulation and method for its manufacture